Loading
Latest filing published 21 Jan 2026 for Jaguar Health, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Steven R. King in Jaguar Health, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 5 April 2022 to 11 December 2025, the count stands at 9 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 21 January 2026: a share grant, in Jaguar Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations